NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021

Area of Science:

• Oncology
• Dermatology
• Clinical Guidelines

Background:

• The NCCN Guidelines for Cutaneous Melanoma undergo regular updates to reflect advancements in diagnosis and treatment.
• Recent updates have focused on expanding treatment pathways and incorporating new principles for managing melanoma.

Purpose of the Study:

• To summarize key modifications and additions to the NCCN Guidelines for Cutaneous Melanoma, v1.2021.
• To highlight changes in pathology, surgical recommendations, and systemic therapy options for advanced melanoma.

Main Methods:

• Review of the NCCN Guidelines for Melanoma: Cutaneous, focusing on updates from v2.2019 to v1.2021.
• Analysis of newly added and revised sections, including microscopic satellitosis, molecular testing, systemic therapy, brain metastases, pathology, surgical margins, sentinel lymph node biopsy, lymph node dissection, and radiation therapy.

Main Results:

• Inclusion of treatment pathways for microscopic satellitosis (v2.2020).
• New Principles sections on Molecular Testing (v2.2019), Systemic Therapy Considerations (v2.2020), and Brain Metastases Management (v3.2020).
• Revisions in v1.2021 to Pathology, Surgical Margins, Sentinel Lymph Node Biopsy, Lymph Node Dissection, and Radiation Therapy principles.

Conclusions:

• The updated NCCN Guidelines offer refined approaches to melanoma diagnosis and treatment.
• Emphasis on molecular testing and systemic therapy for advanced melanoma patients.
• Significant revisions in surgical and pathological recommendations aim to improve patient outcomes.